Alveolar Socket PreservationAlb-PRFNCT06757218
Post Extraction Changes After Alveolar Socket Preservation Using Autogenous Dentin Graft (ADG) Combined With Either Albumin Platelet-rich Fibrin (ALB-PRF) or Standard Platelet-rich Fibrin (PRF).
A study testing empty socket, Autogenous Dentin Graft with Platelet Rich Fibrin and Autogenous Dentin Graft with Albumin Platelet Rich Fibrin in people with Alveolar Socket Preservation, run by Kafrelsheikh University at 1 site in Egypt.
Trial summary
The study focuses on the impact of tooth loss on alveolar bone, which shrinks significantly within the first three months. To prevent this, strategies like alveolar ridge preservation are used. Autogenous dentin, taken from the patient, supports healing and bone regrowth. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Alveolar Socket Preservation
- What is being tested?
- empty socket, Autogenous Dentin Graft with Platelet Rich Fibrin and Autogenous Dentin Graft with Albumin Platelet Rich Fibrin
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jun 2025to 30 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Medically free patients.
- Adult patients above 18 Years to 60 Years.
- Non-restorable tooth indicated for extraction.
- Posterior mandibular teeth.
- Inactive infection related to the tooth.
- Cooperative patients.
Who cannot join
- Presence of any systemic disease that could influence the outcome of the therapy.
- Presence of any risk factor (smoker, pregnant and lactating patients).
- Patients with bone diseases.
- Patients with poor oral hygiene.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Kaferelsheikh University
Kafr ash Shaykh, Kafrelsheikh, 6860404
About this study
Official title: Comparison of Autogenous Dentin Graft With Albumin Platelet Rich Fibrin Versus Autogenous Dentin Graft With Platelet Rich Fibrin in Alveolar Socket Preservation: A Randomized Controlled Clinical Trial.
The study focuses on the impact of tooth loss on alveolar bone, which shrinks significantly within the first three months. To prevent this, strategies like alveolar ridge preservation are used.
Autogenous dentin, taken from the patient, supports healing and bone regrowth. Platelet-rich fibrin (PRF), made from the patient's blood, enhances healing and bone density by releasing growth factors.
A new technique combining L-PRF with albumin creates a stable healing membrane that provides a steady release of growth factors. Overall, these methods improve recovery after tooth extractions and prepare sites for future dental work.
Read the detailed description
Study Design and Randomization:
- Patients classified randomly using computer-generated randomization.
- Performed by the supervisor.
- Three main study groups established.
- Decision for treatment group assignment based on randomized numbers in opaque sealed envelopes, picked by the supervisor.
Groups:
- Control Group:
- 20 sockets with empty sockets to allow spontaneous healing post-extraction.
- Study Group 1:
- 20 sockets receiving autogenous dentin graft and platelet-rich fibrin (PRF) block.
- Study Group 2:
- 20 sockets receiving autogenous dentin graft and Albumin PRF (Alb-PRF) block.
Materials and Preparation
- Autogenous Dentin Graft: The tooth that has been removed will be thoroughly cleaned of any leftover periodontal ligaments, cementum, soft tissue connections, decay, or restorations using a high-speed fine finishing stone along with saline irrigation. Using sterile endodontic files, the pulp chamber will thoroughly be cleaned. Subsequently, the tooth will be ground using a Dentin grinding device to achieve a particle size between 300-1200 μm .The Autogenous Dentin Graft particles will be prepared by demineralizing tooth graft particles through immersion in 0.6N hydrochloric acid for 30 minutes. This will be followed by two rinses with saline and drying with sterile gauze.
- Platelet-Rich Fibrin (PRF): A sample of 10 ml intravenous blood will be collected from the median antecubital vein of the patient. This blood will be placed in 10 ml glass tubes without any additives and will be immediately centrifuged at 3000 RPM for 10 minutes at room temperature. The tube will be separated into three parts, namely, a packed red blood cell at the bottom, acellular plasma at the top, and the PRF clot in between. The PRF clot will be extracted from the tube with the help of sterile tweezers and a surgical blade and then placed in the PRF box to obtain a membrane.
- Albumin Platelet Rich Fibrin (Alb-PRF):
Nine milliliters of blood in plastic tubes will be centrifuged at 700 g for 8 minutes using an Eppendorf centrifugate. The upper layer (platelet-poor plasma layer) was collected in 2-mL syringes and heated at 75°C for 10 minutes to create denatured albumin (albumin gel). Following heating, the albumin gel was allowed to cool to room temperature for 10 minutes. Then, liquid PRF including remaining cells and growth factor found within the buffy coat layer was thereafter mixed back together with the cooled albumin gel to form Alb-PRF using a female-female luer lock connector. This combination allowed that both the lower-resorption properties of the albumin gel along with the higher cell content and growth factor content of the liquid PRF layer to be remixed. The injectable Alb-PRF gels will then be transferred into culture plate forming a gelated ALB-PRF membrane.
Preoperative Evaluation:
- Clinical examination to confirm eligibility.
- Full mouth charting for periodontal evaluation.
- Patient education on plaque control and oral hygiene.
- Supra \& subgingival debridement performed.
Clinical Procedure:
- Pre-extraction rinse with 0.12% chlorhexidine.
- Local anesthesia using 2% mepivacaine HCL with levonordefrin.
- Tooth extraction via minimally traumatic flapless technique.
- Evaluation of extraction socket integrity.
Post-Extraction Treatment
- Control Group: Left the socket empty for healing.
- For the Autogenous Dentin Graft with Platelet Rich Fibrin Block group:
Use surgical curved scissors to cut the two L-PRF membranes into very small pieces, mix chopped membranes and dentin substitute in Ti-dish (2 membranes / 0.5g dentin graft), Add 1 cc of liquid fibrinogen to the homogeneous mixture and gently stir for 5 to 10 seconds while shaping it into the desired form, Fibrinogen will clot into fibrin within a few minutes and trap the biomaterial to form a L-PRF block. the graft will be placed into the socket and will be Covered with a PRF membrane and secured with a single crisscross 5-0 polypropylene suture.
- For the Autogenous Dentin Graft with Albumin Platelet Rich Fibrin group: Mixing the autogenous dentin particles with ALB-PRF in a 1:1 ratio to create a cohesive graft material (dentin block). The graft material is now fully prepared for use. the graft will be placed into the socket and will be Covered with a gelated ALB-PRF membrane. sutured by a single crisscross 5-0 polypropylene suture.
Postsurgical Care Instructions:
- Avoid Trauma: Do not disturb the surgical site or sutures.
- Diet: Avoid hot food and refrain from rinsing your mouth.
- Oral Hygiene: Do not brush the surgical area for 2 weeks; gentle brushing can resume afterward.
- Medications:
- Take Amoxicillin 500mg three times daily for 10 days or Doxycycline 100mg twice daily if allergic to penicillin.
- Use Ibuprofen 600mg for severe pain as needed.
- Mouthwash: Use a 0.12% chlorhexidine mouthwash for gentle rinsing, twice daily for 2 weeks.
- Postoperative Issues: Contact your physician immediately if you experience abnormal bleeding.
- Suture Removal: Sutures will be removed 2 weeks after surgery.
- Follow-up: Schedule a follow-up appointment 6 months after the procedure.
- Conditions
- Alveolar Socket Preservation
- Being tested
- empty socket, Autogenous Dentin Graft with Platelet Rich Fibrin, Autogenous Dentin Graft with Albumin Platelet Rich Fibrin
- Keywords
- Autogenous Dentin Graft, Albumin Platelet Rich Fibrin, Platelet Rich Fibrin
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
empty socketOther
Patients will be left socket empty without any graft materials for spontaneous healing process after tooth extraction
Autogenous Dentin Graft with Platelet Rich FibrinProcedure or surgery
Patients will be inserting autogenous dentin graft and platelet rich fibrin in the socket after extraction.
Autogenous Dentin Graft with Albumin Platelet Rich FibrinProcedure or surgery
Patients will be inserting autogenous dentin graft and Albumin Platelet Rich Fibrin in the socket after extraction.
| Study group | Role | What they receive |
|---|---|---|
| empty socket | Other | Not described Receives: Other: empty socket |
| Autogenous Dentin Graft with Platelet Rich Fibrin | Active comparator | Not described |
| Autogenous Dentin Graft with Albumin Platelet Rich Fibrin | Experimental | Not described Receives: Procedure: Autogenous Dentin Graft with Albumin Platelet Rich Fibrin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Alveolar ridge width (buccolingual).
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the buccolingual width by measuring the distance between buccal and lingual bone walls.
Measured: at baseline immediately after extraction and after six months
Alveolar ridge height (apicocronal)
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the apicocronal height by measuring the ridge height from the top of the alveolar ridge to the upper border of the alveolar canal.
Measured: at baseline immediately after extraction and after six months
Bone density
Will be assessed via Cone-Beam Computed Tomography (CBCT) The measurement helps in assessing the quality of bone directly through Hounsfield units (HU) (between D1 and D5; D1: > 1250 HU, D2: 850 to 1250 HU, D3: 350 to 850 HU, D4: 150 to 350 HU, D5: < 150 HU).
Measured: at baseline immediately after extraction and after six months
Secondary outcomes (3)
Pain scores
The patients will report their pain score directly through VAS score (between 0 and 10; 0: no pain, 1: minimal pain, 5: moderate pain, and 10: severe pain).
Measured: at 24 hours, 3 days, 7 days and 14 days postoperative
Patient satisfaction
Will use Surveys/Questionnaires to assess patient satisfaction regarding treatment outcomes and experiences. The patients will report their satisfaction score directly through satisfaction score (between 0 and 4; 0: Very satisfied, 1: Satisfied, 2: Neither satisfied nor dissatisfied, 3: Dissatisfied, 4: Very dissatisfied).
Measured: at 24 hours, 3 days, 7 days,14 days postoperative and after six months
Keratinized tissue width
Will be assessed through probing techniques before and 6 months after surgical intervention.
The measurements will be taken at the vertical distance from a line connecting the two neighboring teeth at the CEJs to the free gingival margin (FGM) using a UNC 15 probe (Nordent Manufacturing Inc., IL, USA).
Measured: at baseline before extraction and after six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jan 2025
- Study start1 Jun 2025
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alveolar Socket PreservationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A randomized controlled clinical study, Double blinded (patients and biostatistician) with allocation ratio 1:1:1 using 3 - arm parallel groups (2 experimental and control).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kafrelsheikh University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, MUATH ATIF MOHAMEDAHMED HASSAN, Kafrelsheikh University
- Investigators
- Enas Ahmed Elgendy, PhD, Study director, Kaferelsheikh University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06757218
- Sponsor's protocol ID
- KFSIRB200-471
- Acronym
- Alb-PRF
- Status last verified
- Jul 2025
- First submitted
- 26 Dec 2024
- Last updated
- 10 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Autogenous Dentin Graft With Albumin Platelet Rich Fibrin Versus Autogenous Dentin Graft With Platelet Rich Fibrin in Alveolar Socket Preservation: A Randomized Controlled Clinical Trial.
- ClinicalTrials.gov ID
- NCT06757218
- Acronym / sponsor ID
- Alb-PRF / KFSIRB200-471
- Conditions
- Alveolar Socket Preservation
- Keywords
- Autogenous Dentin Graft, Albumin Platelet Rich Fibrin, Platelet Rich Fibrin
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Kafrelsheikh UniversityUniversity, hospital or other
- Study start
- 1 Jun 2025 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Aug 2026 (estimated)
- First posted
- 3 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study focuses on the impact of tooth loss on alveolar bone, which shrinks significantly within the first three months. To prevent this, strategies like alveolar ridge preservation are used.
Autogenous dentin, taken from the patient, supports healing and bone regrowth. Platelet-rich fibrin (PRF), made from the patient's blood, enhances healing and bone density by releasing growth factors.
A new technique combining L-PRF with albumin creates a stable healing membrane that provides a steady release of growth factors. Overall, these methods improve recovery after tooth extractions and prepare sites for future dental work.
Detailed description
Study Design and Randomization:
- Patients classified randomly using computer-generated randomization.
- Performed by the supervisor.
- Three main study groups established.
- Decision for treatment group assignment based on randomized numbers in opaque sealed envelopes, picked by the supervisor.
Groups:
- Control Group:
- 20 sockets with empty sockets to allow spontaneous healing post-extraction.
- Study Group 1:
- 20 sockets receiving autogenous dentin graft and platelet-rich fibrin (PRF) block.
- Study Group 2:
- 20 sockets receiving autogenous dentin graft and Albumin PRF (Alb-PRF) block.
Materials and Preparation
- Autogenous Dentin Graft: The tooth that has been removed will be thoroughly cleaned of any leftover periodontal ligaments, cementum, soft tissue connections, decay, or restorations using a high-speed fine finishing stone along with saline irrigation. Using sterile endodontic files, the pulp chamber will thoroughly be cleaned. Subsequently, the tooth will be ground using a Dentin grinding device to achieve a particle size between 300-1200 μm .The Autogenous Dentin Graft particles will be prepared by demineralizing tooth graft particles through immersion in 0.6N hydrochloric acid for 30 minutes. This will be followed by two rinses with saline and drying with sterile gauze.
- Platelet-Rich Fibrin (PRF): A sample of 10 ml intravenous blood will be collected from the median antecubital vein of the patient. This blood will be placed in 10 ml glass tubes without any additives and will be immediately centrifuged at 3000 RPM for 10 minutes at room temperature. The tube will be separated into three parts, namely, a packed red blood cell at the bottom, acellular plasma at the top, and the PRF clot in between. The PRF clot will be extracted from the tube with the help of sterile tweezers and a surgical blade and then placed in the PRF box to obtain a membrane.
- Albumin Platelet Rich Fibrin (Alb-PRF):
Nine milliliters of blood in plastic tubes will be centrifuged at 700 g for 8 minutes using an Eppendorf centrifugate. The upper layer (platelet-poor plasma layer) was collected in 2-mL syringes and heated at 75°C for 10 minutes to create denatured albumin (albumin gel). Following heating, the albumin gel was allowed to cool to room temperature for 10 minutes. Then, liquid PRF including remaining cells and growth factor found within the buffy coat layer was thereafter mixed back together with the cooled albumin gel to form Alb-PRF using a female-female luer lock connector. This combination allowed that both the lower-resorption properties of the albumin gel along with the higher cell content and growth factor content of the liquid PRF layer to be remixed. The injectable Alb-PRF gels will then be transferred into culture plate forming a gelated ALB-PRF membrane.
Preoperative Evaluation:
- Clinical examination to confirm eligibility.
- Full mouth charting for periodontal evaluation.
- Patient education on plaque control and oral hygiene.
- Supra \& subgingival debridement performed.
Clinical Procedure:
- Pre-extraction rinse with 0.12% chlorhexidine.
- Local anesthesia using 2% mepivacaine HCL with levonordefrin.
- Tooth extraction via minimally traumatic flapless technique.
- Evaluation of extraction socket integrity.
Post-Extraction Treatment
- Control Group: Left the socket empty for healing.
- For the Autogenous Dentin Graft with Platelet Rich Fibrin Block group:
Use surgical curved scissors to cut the two L-PRF membranes into very small pieces, mix chopped membranes and dentin substitute in Ti-dish (2 membranes / 0.5g dentin graft), Add 1 cc of liquid fibrinogen to the homogeneous mixture and gently stir for 5 to 10 seconds while shaping it into the desired form, Fibrinogen will clot into fibrin within a few minutes and trap the biomaterial to form a L-PRF block. the graft will be placed into the socket and will be Covered with a PRF membrane and secured with a single crisscross 5-0 polypropylene suture.
- For the Autogenous Dentin Graft with Albumin Platelet Rich Fibrin group: Mixing the autogenous dentin particles with ALB-PRF in a 1:1 ratio to create a cohesive graft material (dentin block). The graft material is now fully prepared for use. the graft will be placed into the socket and will be Covered with a gelated ALB-PRF membrane. sutured by a single crisscross 5-0 polypropylene suture.
Postsurgical Care Instructions:
- Avoid Trauma: Do not disturb the surgical site or sutures.
- Diet: Avoid hot food and refrain from rinsing your mouth.
- Oral Hygiene: Do not brush the surgical area for 2 weeks; gentle brushing can resume afterward.
- Medications:
- Take Amoxicillin 500mg three times daily for 10 days or Doxycycline 100mg twice daily if allergic to penicillin.
- Use Ibuprofen 600mg for severe pain as needed.
- Mouthwash: Use a 0.12% chlorhexidine mouthwash for gentle rinsing, twice daily for 2 weeks.
- Postoperative Issues: Contact your physician immediately if you experience abnormal bleeding.
- Suture Removal: Sutures will be removed 2 weeks after surgery.
- Follow-up: Schedule a follow-up appointment 6 months after the procedure.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- A randomized controlled clinical study, Double blinded (patients and biostatistician) with allocation ratio 1:1:1 using 3 - arm parallel groups (2 experimental and control).
| Arm | Type | Receives |
|---|---|---|
| empty socket | Other | Other: empty socket |
| Autogenous Dentin Graft with Platelet Rich Fibrin | Active comparator | – |
| Autogenous Dentin Graft with Albumin Platelet Rich Fibrin | Experimental | Procedure: Autogenous Dentin Graft with Albumin Platelet Rich Fibrin |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Medically free patients.
- Adult patients above 18 Years to 60 Years.
- Non-restorable tooth indicated for extraction.
- Posterior mandibular teeth.
- Inactive infection related to the tooth.
Key exclusion criteria (4 listed)
- Presence of any systemic disease that could influence the outcome of the therapy.
- Presence of any risk factor (smoker, pregnant and lactating patients).
- Patients with bone diseases.
- Patients with poor oral hygiene.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| empty socketPatients will be left socket empty without any graft materials for spontaneous healing process after tooth extraction | Other | empty socket |
| Autogenous Dentin Graft with Platelet Rich FibrinPatients will be inserting autogenous dentin graft and platelet rich fibrin in the socket after extraction. | Procedure or surgery | – |
| Autogenous Dentin Graft with Albumin Platelet Rich FibrinPatients will be inserting autogenous dentin graft and Albumin Platelet Rich Fibrin in the socket after extraction. | Procedure or surgery | Autogenous Dentin Graft with Albumin Platelet Rich Fibrin |
Primary outcome
Alveolar ridge width (buccolingual).
Time frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the buccolingual width by measuring the distance between buccal and lingual bone walls.
Alveolar ridge height (apicocronal)
Time frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) that Provides a radiographic assessment of the apicocronal height by measuring the ridge height from the top of the alveolar ridge to the upper border of the alveolar canal.
Bone density
Time frame: at baseline immediately after extraction and after six months
Will be assessed via Cone-Beam Computed Tomography (CBCT) The measurement helps in assessing the quality of bone directly through Hounsfield units (HU) (between D1 and D5; D1: > 1250 HU, D2: 850 to 1250 HU, D3: 350 to 850 HU, D4: 150 to 350 HU, D5: < 150 HU).
3 secondary outcomes
Pain scores
Time frame: at 24 hours, 3 days, 7 days and 14 days postoperative
Patient satisfaction
Time frame: at 24 hours, 3 days, 7 days,14 days postoperative and after six months
Keratinized tissue width
Time frame: at baseline before extraction and after six months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Alveolar Socket Preservation
Recruiting
Effect of Collagen Membrane on Ridge Preservation
Dehiscence, Tooth Extraction
RecruitingPhase 4
Biotivity A-C Membrane Socket Preservation Study
Alveolar Ridge Preservation
Active, not recruiting
Vallomix Socket Preservation Study
Alveolar Ridge Augmentation
Not yet recruiting
Bone and Soft Tissue Healing After Socket Preservation With NOVAMag or Permamem Membranes
Alveolar Bone Loss, Tooth Loss / Rehabilitation
Recruiting
Different Approaches for Alveolar Ridge Preservation
Alveolar Ridge Resorption
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Enas Ahmed Elgendy, PhD study director
Kaferelsheikh University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing empty socket, Autogenous Dentin Graft with Platelet Rich Fibrin and Autogenous Dentin Graft with Albumin Platelet Rich Fibrin in people with Alveolar Socket Preservation, run by Kafrelsheikh University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact MUATH ATIF HASSAN (+201507571780, muath_01pg@den.kfs.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Alveolar ridge width (buccolingual). (time frame: at baseline immediately after extraction and after six months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2025.